192 related articles for article (PubMed ID: 31610271)
1. Symptom Clusters in Women With Breast Cancer During the First 18 Months of Adjuvant Therapy.
Li H; Sereika SM; Marsland AL; Conley YP; Bender CM
J Pain Symptom Manage; 2020 Feb; 59(2):233-241. PubMed ID: 31610271
[TBL] [Abstract][Full Text] [Related]
2. Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy.
Li H; Sereika SM; Marsland AL; Conley YP; Bender CM
J Clin Nurs; 2019 Dec; 28(23-24):4560-4571. PubMed ID: 31469461
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.
Sheng JY; Blackford AL; Bardia A; Venkat R; Rosson G; Giles J; Hayes DF; Jeter SC; Zhang Z; Hayden J; Nguyen A; Storniolo AM; Tarpinian K; Henry NL; Stearns V
Breast Cancer Res Treat; 2019 Aug; 176(3):617-624. PubMed ID: 31079282
[TBL] [Abstract][Full Text] [Related]
4. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC
Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
[TBL] [Abstract][Full Text] [Related]
5. Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
Borreani C; Alfieri S; Infante G; Miceli R; Mariani P; Bosisio M; Vernieri C; Bianchi GV; Capri G
Oncology; 2021; 99(2):84-95. PubMed ID: 32992318
[TBL] [Abstract][Full Text] [Related]
6. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M
Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons.
Markopoulos C; Koukouras D; Venizelos V; Karyda I; Xepapadakis G; Misitzis J; Kalogerakos K; Poulakaki F; Natsiopoulos J; Zobolas V; Savidou C; Antonopoulou Z; Tzoracoleftherakis E
Breast; 2016 Jun; 27():27-34. PubMed ID: 27212697
[TBL] [Abstract][Full Text] [Related]
8. Genes Involved in the HPA Axis and the Symptom Cluster of Fatigue, Depressive Symptoms, and Anxiety in Women With Breast Cancer During 18 Months of Adjuvant Therapy.
Li H; Marsland AL; Conley YP; Sereika SM; Bender CM
Biol Res Nurs; 2020 Apr; 22(2):277-286. PubMed ID: 31908177
[TBL] [Abstract][Full Text] [Related]
9. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
Nakatsukasa K; Koyama H; Ouchi Y; Ono H; Sakaguchi K; Matsuda T; Kato M; Ishikawa T; Yamada K; Yoshimura M; Koizumi K; Sakurai T; Shigematsu H; Takahashi S; Taira S; Suzuki M; Narui K; Niikura N; Hasegawa Y; Miura D; Konishi E; Taguchi T;
Breast Cancer; 2019 Jan; 26(1):106-112. PubMed ID: 30054855
[TBL] [Abstract][Full Text] [Related]
10. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
Bhave MA; Speth KA; Kidwell KM; Lyden A; Alsamarraie C; Murphy SL; Henry NL
Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
[TBL] [Abstract][Full Text] [Related]
11. Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.
Stearns V; Chapman JA; Ma CX; Ellis MJ; Ingle JN; Pritchard KI; Budd GT; Rabaglio M; Sledge GW; Le Maitre A; Kundapur J; Liedke PE; Shepherd LE; Goss PE
J Clin Oncol; 2015 Jan; 33(3):265-71. PubMed ID: 25512454
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy.
Custódio IDD; Nunes FSM; Lima MTM; de Carvalho KP; Alves DS; Chiaretto JF; Canto PPL; Paiva CE; de Paiva Maia YC
BMC Cancer; 2022 Aug; 22(1):860. PubMed ID: 35933326
[TBL] [Abstract][Full Text] [Related]
13. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
[TBL] [Abstract][Full Text] [Related]
14. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.
Schover LR; Baum GP; Fuson LA; Brewster A; Melhem-Bertrandt A
J Sex Med; 2014 Dec; 11(12):3102-11. PubMed ID: 25141792
[TBL] [Abstract][Full Text] [Related]
15. Symptom clusters among breast cancer patients in relation to chemotherapy cycles: a longitudinal study.
Luo R; Chen H; Liu Y; Sun H; Tang S; Chen Y
Support Care Cancer; 2023 Sep; 31(10):573. PubMed ID: 37698687
[TBL] [Abstract][Full Text] [Related]
16. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.
Graetz I; McKillop CN; Stepanski E; Vidal GA; Anderson JN; Schwartzberg LS
J Cancer Surviv; 2018 Aug; 12(4):431-440. PubMed ID: 29492753
[TBL] [Abstract][Full Text] [Related]
17. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.
Liu L; Fiorentino L; Natarajan L; Parker BA; Mills PJ; Sadler GR; Dimsdale JE; Rissling M; He F; Ancoli-Israel S
Psychooncology; 2009 Feb; 18(2):187-94. PubMed ID: 18677716
[TBL] [Abstract][Full Text] [Related]
19. Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.
Sitlinger A; Shelby RA; Van Denburg AN; White H; Edmond SN; Marcom PK; Bosworth HB; Keefe FJ; Kimmick GG
J Geriatr Oncol; 2019 Mar; 10(2):317-321. PubMed ID: 30553719
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
